default author photo

Jean-Sebastien Casalegno

Hospices Civils de Lyon - Laboratoire de Virologie

France

SCHOLARLY PAPERS

4

DOWNLOADS

797

TOTAL CITATIONS
Rank 43,100

SSRN RANKINGS

Top 43,100

in Total Papers Citations

30

Scholarly Papers (4)

1.

Real-World Emergence of Nirsevimab Resistance in RSV-B Breakthrough Infections

Number of pages: 25 Posted: 08 Sep 2025
Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris Saclay, Université Paris Cité - Institut Pasteur, Hospices Civils de Lyon - Laboratoire de Virologie, University of Paris-Saclay - Institut Pasteur, Paris-Est University - Inserm U955, Centre Hospitalier de Bretagne Sud - Laboratoire de biologie médicale, Université de Toulouse - CHU de Toulouse, University of Nantes - CHU Nantes, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, Hôpital Necker-Enfants Malades, University of Montpellier - Virulence bactérienne et infections chroniques (VBIC), CHU Poitiers, University of Bordeaux, Hôpital Paul-Brousse - Service de Virologie, Sorbonne University, Université Paris VI Pierre et Marie Curie - Hôpital Saint-Antoine, CHU de Rennes - Department of Virology, CHRU Tours, University of Strasbourg - Federation of Translational Medicine of Strasbourg (FMTS), University Grenoble Alpes - Centre Hospitalier Universitaire de Grenoble (CHU Grenoble Alpes), University of Lille - CHU Lille, CHU Caen, Centre Hospitalier Victor Dupouy, University of Paris-Saclay - Laboratoire de Microbiologie, University of Lorraine - CNRS, LCPME, F-54000, Université Paris Nord - Laboratoire de Microbiologie Clinique, CHU Rouen, Université d’Orléans, University of Angers - CHU Angers, CHU Montpellier, Amiens Picardie University Hospital - Department of Virology, Université Clermont Auvergne - CHU Clermont-Ferrand, Université Paris 7, Hôpital Saint Louis - Service de Virologie, Université Paris Cité, CHU La Réunion - Hôpital F Guyon, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University Hospital of Henri-Mondor, APHP - Department of Microbiology, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, CHU de la Martinique, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, Centre Hospitalier de Bretagne Sud - Laboratoire de biologie médicale, Hôpital Henri Mondor - Université Paris-Est, "Viruses, Hepatology, Cancer" Research Unit, University of Paris-Saclay - Institut Pasteur, Université Paris Est Créteil (UPEC) - IMRB, Université Paris Saclay and Independent
Downloads 302 (250,461)

Abstract:

Loading...

RSV, immunoprphylaxis, nirsevimab, resistance

2.

Genotypic and Phenotypic Characterisation of Rsv after Nirsevimab Breakthrough Infections in a Large Multicentre Observational Real-World Study

Number of pages: 30 Posted: 16 Jul 2024
Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris Saclay, Université Paris Cité - Institut Pasteur, Hospices Civils de Lyon - Laboratoire de Virologie, University of Paris-Saclay - Institut Pasteur, Centre Hospitalier de Bretagne Sud - Laboratoire de biologie médicale, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, Université de Toulouse - CHU de Toulouse, CHU Caen, University of Paris-Saclay - Laboratoire de Microbiologie, Université Paris 7, Hôpital Saint Louis - Service de Virologie, University of Nantes - CHU Nantes, Université Clermont Auvergne - CHU Clermont-Ferrand, University Grenoble Alpes - Centre Hospitalier Universitaire de Grenoble (CHU Grenoble Alpes), CHU Rouen, Sorbonne University - Laboratoire de virologie, Université Paris VI Pierre et Marie Curie - Hôpital Saint-Antoine, Hôpital Necker-Enfants Malades, CHU Montpellier, CHRU Tours, Centre Hospitalier Victor Dupouy, CHRU Brest - Morvan, Université Paris Nord - Laboratoire de Microbiologie Clinique, Université d’Orléans, University of Bordeaux - CHU de Bordeaux, University of Angers - CHU Angers, CHU de Rennes - Department of Virology, CHU Poitiers, Université Paris Cité, Hôpital Paul-Brousse - Service de Virologie, Amiens Picardie University Hospital - Department of Virology, University of Lille - CHU Lille, University of Lorraine - CNRS, LCPME, F-54000, University of Limoges - CHU Limoges, University of Strasbourg - Federation of Translational Medicine of Strasbourg (FMTS), Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University Hospital of Henri-Mondor, APHP - Department of Microbiology, CHU de la Martinique, University of Paris-Saclay - Institut Pasteur, Université Paris Cité, Hôpital Henri Mondor - Université Paris-Est, "Viruses, Hepatology, Cancer" Research Unit, Université Paris Cité - Institut Pasteur, Université Paris Est Créteil (UPEC) - IMRB, Université Paris Saclay and Independent
Downloads 271 (280,513)

Abstract:

Loading...

RSV, breakthrough infection, monoclonal antibodies, nirsevimab, resistance

3.

Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Young Children in 2019: A Systematic Analysis

Number of pages: 35 Posted: 18 Jan 2022
Nanjing Medical University, Nanjing Medical University - School of Public Health, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Comisión de Investigaciones Científicas de la Provincia de Buenos Aires (CIC) - Consejo Nacional de Investigaciones Científicas y Técnicas, World Health Organization (WHO) - Department of Immunization, Vaccines and Biologicals (IVB), Boston University - Department of Global Health, Chris Hani Baragwanath Academic Hospital - Vaccines and Infectious Diseases Analytics Research Unit, Yale University - Institute for Global Health, University of Colorado at Denver - Department of Pediatrics, University of Edinburgh - College of Medicine & Veterinary Medicine, affiliation not provided to SSRN, National Center for Communicable Diseases, University of Barcelona - Institut de Salut Global de Barcelona (ISGlobal), Hospices Civils de Lyon - Laboratoire de Virologie, NCDC, University of Melbourne - Infection and Immunity, Smorodintsev Research Institute of Influenza, University of Melbourne - Infection and Immunity, affiliation not provided to SSRN, Hospital de Niños R. Gutiérrez, University of Michigan at Ann Arbor - Department of Epidemiology, University of Turku - Department of Pediatrics, National Centre for Biosecurity and Infectious Disease (NCBID) - Institute of Environmental Science and Research Limited (ESR), affiliation not provided to SSRN, All India Institute of Medical Sciences (AIIMS), New Delhi, affiliation not provided to SSRN, University of Split, FISABIO-Public Health, Perth Children’s Hospital - Telethon Kids Institute, National Health Laboratory Services (NHLS) - Centre for Respiratory Diseases and Meningitis, affiliation not provided to SSRN, University of Warwick, affiliation not provided to SSRN, affiliation not provided to SSRN, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), affiliation not provided to SSRN, Tehran University of Medical Sciences, MAHAN Trust Mahatma Gandhi Tribal Hospital, affiliation not provided to SSRN, Hospital de Santa Maria, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of the Witwatersrand - Department of Clinical Microbiology and Infectious Diseases, affiliation not provided to SSRN, Nagasaki University - Department of Pediatric Infectious Diseases, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, University of Cape Town (UCT) - Department of Pediatrics and Child Health, affiliation not provided to SSRN, University of Edinburgh - College of Medicine & Veterinary Medicine and affiliation not provided to SSRN
Downloads 164 (456,852)
Citation 30

Abstract:

Loading...

Respiratory Syncytial Virus, disease burden, global burden, acute lower respiratory infection, children, pneumonia, bronchiolitis, epidemiology, mortality

4.

Identifying the Target Population for Primary Respiratory Syncytial Virus Two-Step Prevention in Infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN)

Number of pages: 23 Posted: 08 Feb 2022
Hospices Civils de Lyon - Laboratoire de Virologie, Hospices Civils de Lyon - Department of Medicine and Reproduction, Hospices Civils de Lyon - Department of Medicine and Reproduction, Hospices Civils de Lyon - Department of Medicine and Reproduction, Hospices Civils de Lyon - Department of Pediatric Emergency and Intensive Care Unit, Hospices Civils de Lyon - Department of Medicine and Reproduction, Université Lyon 1 - Centre International de Recherche en Infectiologie (CIRI), Hospices Civils de Lyon - Department of Obstetrics and Gynaecology Surgery, Hospices Civils de Lyon - Department of Obstetrics and Gynaecology Surgery, University of Claude Bernard Lyon 1 - CIRI, affiliation not provided to SSRN and Hospices Civils de Lyon - Laboratoire de Virologie
Downloads 60 (961,006)

Abstract:

Loading...

RSV, Bronchiolitis, Predictive Score, Lower Respiratory Tract Infection, Primary prevention, monoclonal antibody, public health, vaccines